当前位置:首页 - 行情中心 - 诚达药业(301201) - 财务分析 - 现金流量表

诚达药业

(301201)

  

流通市值:45.53亿  总市值:64.90亿
流通股本:1.09亿   总股本:1.55亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金337,456,785.95209,499,121.9863,888,356.57423,016,713.16
  收到的税费返还2,710,909.412,388,382.8630.67-
  收到其他与经营活动有关的现金19,971,655.78,579,640.392,865,624.1817,379,987.6
  经营活动现金流入小计360,139,351.06220,467,145.2366,754,011.42440,396,700.76
  购买商品、接受劳务支付的现金178,074,991.1124,165,522.0855,909,701.84194,033,908.41
  支付给职工以及为职工支付的现金71,171,518.6747,336,951.3921,095,032.4281,606,213.72
  支付的各项税费5,985,608.265,440,443.484,683,368.7719,728,524.88
  支付其他与经营活动有关的现金38,445,335.1120,133,318.028,027,478.95116,379,677.97
  经营活动现金流出小计293,677,453.14197,076,234.9789,715,581.98411,748,324.98
  经营活动产生的现金流量净额66,461,897.9223,390,910.26-22,961,570.5628,648,375.78
二、投资活动产生的现金流量:
  收回投资收到的现金5,829,968,276.273,460,022,696.251,838,022,696.253,129,014,887.79
  取得投资收益收到的现金17,353,463.569,904,454.464,092,635.6630,786,457.23
  处置固定资产、无形资产和其他长期资产收回的现金净额256,717231,72556,0002,148,530.97
  投资活动现金流入小计5,847,578,456.833,470,158,875.711,842,171,331.913,161,949,875.99
  购建固定资产、无形资产和其他长期资产支付的现金110,558,933.0174,434,947.5934,875,665.02286,364,987.86
  投资支付的现金5,124,000,0002,785,000,0001,500,000,0004,085,063,218.15
  投资活动现金流出小计5,234,558,933.012,859,434,947.591,534,875,665.024,371,428,206.01
  投资活动产生的现金流量净额613,019,523.82610,723,928.12307,295,666.89-1,209,478,330.02
三、筹资活动产生的现金流量:
  吸收投资收到的现金---380,000
  其中:子公司吸收少数股东投资收到的现金---380,000
  取得借款收到的现金8,079,3008,079,3008,079,30080,118,379.9
  收到其他与筹资活动有关的现金---0
  筹资活动现金流入小计8,079,3008,079,3008,079,30080,498,379.9
  偿还债务支付的现金30,000,000---
  分配股利、利润或偿付利息支付的现金30,921,641.611,237,233.96606,130.5730,548,288.77
  支付其他与筹资活动有关的现金---57,073,347.67
  筹资活动现金流出小计60,921,641.611,237,233.96606,130.5787,621,636.44
  筹资活动产生的现金流量净额-52,842,341.616,842,066.047,473,169.43-7,123,256.54
四、汇率变动对现金及现金等价物的影响641,316.71683,532.64225,712.162,205,466.9
五、现金及现金等价物净增加额627,280,396.84641,640,437.06292,032,977.92-1,185,747,743.88
  加:期初现金及现金等价物余额176,941,170.9176,941,170.9178,463,170.91,362,688,914.78
  期末现金及现金等价物余额804,221,567.74818,581,607.96470,496,148.82176,941,170.9
补充资料:
  净利润-12,995,531.41--27,639,162.41
  资产减值准备-4,184,500.97-3,085,916.41
  固定资产和投资性房地产折旧-34,430,870.83-45,659,601.77
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-34,430,870.83-45,659,601.77
  无形资产摊销-770,048.1-1,498,414.21
  长期待摊费用摊销-8,624,562.17-14,247,163.55
  处置固定资产、无形资产和其他长期资产的损失--37,332.75--204,739.69
  固定资产报废损失-445,480.02-2,531,986.26
  公允价值变动损失--2,964,478.63--1,603,689.96
  财务费用--755,430.47--1,910,128.64
  投资损失--6,273,243.09--30,786,457.23
  递延所得税--992,744.01--441,741.43
  其中:递延所得税资产减少--489,061.73--378,846.37
    递延所得税负债增加--503,682.28--62,895.06
  存货的减少--20,844,628.7--12,589,910.61
  经营性应收项目的减少--22,511,366.5--35,468,675.59
  经营性应付项目的增加-10,548,886.24-71,648,899.14
  其他-5,770,254.67-620,900
  现金的期末余额-818,581,607.96-176,941,170.9
  减:现金的期初余额-176,941,170.9-1,362,688,914.78
  现金及现金等价物的净增加额-641,640,437.06--1,185,747,743.88
公告日期2025-10-282025-08-262025-04-252025-04-25
审计意见(境内)标准无保留意见
TOP↑